Newsbenzinga
B. Riley Securities Initiates Coverage On Veradermics with Buy Rating, Announces Price Target of $170
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…